Literature DB >> 4163144

Parietal-cell antibodies in patients with duodenal ulcer and gastric cancer.

R E Kravetz, S Van Noorden, H M Spiro.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 4163144     DOI: 10.1016/s0140-6736(67)91299-8

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  10 in total

1.  Parietal cell antibodies. Part I. Clinical and pathological studies of parietal cell antibodies.

Authors:  K Kogawa
Journal:  Gastroenterol Jpn       Date:  1975

2.  Diabetes mellitus and concurrent autoimmune disease.

Authors:  M I Drury; F J Timoney
Journal:  Ir J Med Sci       Date:  1974-01       Impact factor: 1.568

Review 3.  A reappraisal of the nature and significance of chronic atrophic gastritis.

Authors:  R G Strickland; I R Mackay
Journal:  Am J Dig Dis       Date:  1973-05

4.  Hypoglycemia in renal disease.

Authors:  S L Dua
Journal:  West J Med       Date:  1974-02

5.  Parietal-cell antibodies in patients undergoing gastric surgery.

Authors:  P M Ashurst
Journal:  Br Med J       Date:  1968-06-15

6.  Gastric secretory response to iron therapy.

Authors:  W D Stone
Journal:  Gut       Date:  1968-02       Impact factor: 23.059

7.  Gastritis and gastric cancer.

Authors: 
Journal:  Br Med J       Date:  1972-05-06

8.  The prevalence and significance of circulating antibodies to gastric intrinsic factor and parietal cells in gastric carcinoma.

Authors:  B Ungar; R G Strickland; C M Francis
Journal:  Gut       Date:  1971-11       Impact factor: 23.059

9.  Gastric mucosa after partial gastrectomy.

Authors:  B M Pulimood; A Knudsen; N F Coghill
Journal:  Gut       Date:  1976-06       Impact factor: 23.059

10.  Simple atrophic gastritis and gastric carcinoma.

Authors:  I R Walker; R G Strickland; B Ungar; I R Mackay
Journal:  Gut       Date:  1971-11       Impact factor: 23.059

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.